Literature DB >> 21296215

Centralized intravenous additive services (CIVAS): the state of the art in 2010.

J-D Hecq1.   

Abstract

In hospitals, the major part of the drugs is administered by intravenous way and the majority of the reconstitution of injectable drugs are carried out right before the administration to the patient by the nursing staff. The risks and errors related to the preparation and the administration of the injectable drugs are numerous. The standardization then the centralization of the preparations and reconstitution by the hospital pharmacy make it possible to reduce these various risks and errors. In addition to the preparation of the mixtures of parenteral nutrition as well as doses of anticancer chemotherapy, many other treatments can be taken in charge, such as antibiotics, antiemetics and pain treatments. Consequent equipment is necessary but the realization of these treatments proves non-overdrawn insofar as a certain quantity of production is reached. The reconstitution of the intravenous treatments by a centralized intravenous admixture service guarantees the chemical stability and the microbiological quality of the ready-to-use injectable drugs and contributes to the quality and the total management of the care of the patient.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21296215     DOI: 10.1016/j.pharma.2010.09.002

Source DB:  PubMed          Journal:  Ann Pharm Fr        ISSN: 0003-4509


  6 in total

1.  Long-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different Containers.

Authors:  M L Colsoul; A Breuer; N Goderniaux; J D Hecq; L Soumoy; B Bihin; J Jamart; L Galanti
Journal:  Hosp Pharm       Date:  2019-03-12

2.  Long-term stability of an infusion containing paracetamol, alizapride, ketorolac and tramadol in glass bottles at 5±3°C.

Authors:  Marie-Lise Colsoul; Jean-Daniel Hecq; Laura Soumoy; Océane Charles; Nicolas Goderniaux; Benoît Bihin; Jacques Jamart; Laurence Galanti
Journal:  Eur J Hosp Pharm       Date:  2019-06-11

3.  Long-term stability of ready-to-use norepinephrine solution at 0.2 and 0.5 mg/mL.

Authors:  Sixtine Gilliot; Morgane Masse; Stéphanie Genay; Damien Lannoy; Christine Barthélémy; Bertrand Décaudin; Pascal Odou
Journal:  Eur J Hosp Pharm       Date:  2020-02-06

4.  Semiautomated aseptic preparation of patient-individual antineoplastic intravenous solutions: first experiences in a German hospital pharmacy.

Authors:  Tilman Schoening; Adelia Artes; Martin Ehmann; Mieke Mertens; Michael Ober; Torsten Hoppe-Tichy
Journal:  Eur J Hosp Pharm       Date:  2015-09-03

5.  Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?

Authors:  M Closset; J D Hecq; E Gonzalez; B Bihin; J Jamart; L Galanti
Journal:  Eur J Hosp Pharm       Date:  2016-10-12

6.  Microbial contamination of single- and multiple-dose vials after opening in a pulmonary teaching hospital.

Authors:  Shadi Baniasadi; Atosa Dorudinia; Mandana Mobarhan; Masoumeh Karimi Gamishan; Fanak Fahimi
Journal:  Braz J Infect Dis       Date:  2013-01-05       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.